Alterity Therapeutics Ltd
ASX:ATH
Alterity Therapeutics Ltd
ASX:ATH
Price:
0.008
AUD
6.67%
Market Closed
Market Cap:
AU$87m
Relative Value
The Relative Value of one
ATH
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.008 AUD,
Alterity Therapeutics Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ATH Relative Value
HIDDEN
Multiples Across Competitors
ATH Competitors Multiples
Alterity Therapeutics Ltd Competitors
Alterity Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Alterity Therapeutics Ltd
ASX:ATH
|
87m AUD | 194.9 | -7.2 | -3.8 | -3.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
407.7B USD | 6.7 | 97.4 | 16 | 22.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208.4B USD | 5.7 | 27 | 15.4 | 15.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.3B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.9B USD | 10.5 | 31.8 | 24.4 | 25.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
71.1B AUD | 3.2 | 16.7 | 11.5 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 13.1 | 30.9 | 52.4 | 53.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
